Thai-developed COVID-19 vaccine starts human trials
Thailand started human trials on Monday of a domestically developed coronavirus vaccine and expects to deploy it next year, which its health minister said could give the country more freedom with its vaccine policy.
Thailand’s vaccination drive is targeting the inoculation of half of its adult population by the end of the year using 61 million doses of AstraZeneca’s vaccine, which will be locally produced from June.
